Company Overview

SK3 Group, Inc. (OTC Pink: SKTO) is a publicly traded microcap holding company that has historically been associated with the cannabis and medical marijuana sector through various subsidiaries and business initiatives disclosed in OTC market filings and company releases. Public disclosures indicate the company pursued opportunities tied to cannabis cultivation, licensing, consulting, and related healthcare-oriented ventures during the early expansion phase of the U.S. medical marijuana industry. Available records suggest the company primarily operated as a development-stage issuer rather than as a large-scale operating enterprise.

The company’s historical business model centered on acquiring or developing interests in cannabis-related entities and positioning itself within emerging state-level medical marijuana markets in the United States. Publicly available information indicates that SK3 Group explored revenue opportunities through subsidiary operations, strategic partnerships, and intellectual-property-oriented cannabis initiatives. However, current operational scale, active revenue generation, and ongoing business activity are difficult to independently verify through recent audited filings. Data inconclusive based on available public sources.

Business Operations

Historical disclosures reference operations conducted through subsidiaries and affiliated cannabis ventures, including entities tied to cultivation, dispensary support services, and licensing arrangements. The company’s business structure appeared to rely on holding-company ownership interests rather than vertically integrated operations. Public filings and OTC disclosures also referenced activities connected to medical cannabis branding and advisory services during periods when U.S. state legalization frameworks were expanding.

Available public information does not clearly confirm the company’s current operating segments, active assets, or sustained commercial operations. There is limited independently verified evidence of substantial international business activity, large-scale production infrastructure, or material recurring revenue in recent periods. While earlier company communications referenced strategic relationships within the cannabis ecosystem, the current status of those partnerships or subsidiaries cannot be fully verified from recent public records.

Strategic Position & Investments

SK3 Group historically positioned itself as an early-stage participant in the regulated cannabis sector, seeking exposure to anticipated growth in medical marijuana legalization and related healthcare markets. Publicly available materials indicate the company pursued investments and affiliations intended to capitalize on evolving regulatory changes within the United States cannabis industry. Its strategic approach appeared focused on establishing ownership interests and partnerships rather than developing large independent operating facilities.

The company’s publicly disclosed investment and acquisition activity was limited in scale compared with larger cannabis operators. Historical references to acquisitions, subsidiary formations, and cannabis-sector investments exist in OTC disclosures and company communications, but many of these initiatives lack recent independently verified operational updates. Data concerning active portfolio companies, current investment holdings, or emerging technology initiatives remains inconclusive based on available public sources.

Geographic Footprint

SK3 Group’s historical operations were primarily associated with the United States, particularly states involved in early medical marijuana legalization efforts. Public disclosures did not indicate a broad multinational operating footprint or significant overseas expansion. The company’s corporate activities were largely tied to U.S. cannabis regulatory developments and domestic partnership opportunities.

There is limited verified evidence of material operations outside North America. Public records do not currently demonstrate a substantial international investment presence, global production network, or major foreign subsidiaries. Headquarters and operational infrastructure details have varied across historical disclosures, and recent independently verified location information is limited.

Leadership & Governance

Public information regarding SK3 Group’s leadership and governance structure is limited and in some cases outdated. Historical OTC disclosures and company communications referenced executives and officers associated with the company during its cannabis-sector expansion efforts, but recent verified governance disclosures appear limited. As a result, some leadership information may no longer reflect the company’s current management structure.

Known historical leadership references include:

• Michael M. Berman – Former executive leadership role associated with company operations and public communications
• Monroe M. M. – Historical officer/director references appear in certain public disclosures; current status inconclusive

The company’s publicly communicated strategic vision historically emphasized participation in emerging regulated cannabis markets through acquisitions, partnerships, and subsidiary development. However, recent governance transparency and operational reporting appear limited compared with fully reporting SEC registrants.